Advertisement

Supply Chain



Erez Vigodman stepped down from his role as president and CEO of Teva Pharmaceuticals, reports the Philadelphia Business Journal.

Canonsburg, Pa.-based Mylan will pay $96.5 million to settle a class-action lawsuit alleging it entered a "pay-to-delay" deal with the drugmaker Cephalon, reports Bloomberg.

Express Scripts — the largest pharmacy benefit manager in the U.S. — released its 2016 Drug Trend Report showing prescription drug spending slowed for its members last year.

Advertisement